Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keaise Medical Laboratory is a specialized third-party clinical testing facility based in the Zhangjiang Hi-Tech Park of Shanghai, China. The company provides a broad spectrum of diagnostic services, including molecular pathology, clinical chemistry, and immunology, with a particular focus on precision oncology and companion diagnostics. In addition to clinical practice, Keaise serves as a central laboratory for pharmaceutical companies, supporting Phase I-IV clinical trials with biomarker analysis and patient enrollment screening. The laboratory utilizes advanced platforms such as next-generation sequencing (NGS) and mass spectrometry to deliver high-quality, regulated data. Its services are integral to the development of personalized medicine and the advancement of targeted therapies in the Chinese market. The company maintains rigorous quality control standards to ensure compliance with both domestic and international regulatory requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keaise Clinical Examination Lab.